Insulet (PODD) Divestments (2016)
Insulet posted quarterly Divestments of $1.1 million for Q2 2016, down 76.16% on a QoQ basis from $4.6 million in Q1 2016.
Insulet (PODD) has 1 years of Divestments data on file, last reported at $1.1 million in Q2 2016.
- For the quarter ending Q2 2016, Divestments changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2017 stood at $1.1 million (down 76.16% YoY), and the FY2016 full-year result was $5.7 million, changed N/A from the prior year.
- Divestments for Q2 2016 stood at $1.1 million, down from $4.6 million in the prior quarter.
- Across five years, Divestments topped out at $4.6 million in Q1 2016 and bottomed at $1.1 million in Q2 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 1.10 Mn |
| Mar 31, 2016 | 4.61 Mn |